<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Screening Breast MRI in Patients Previously Treated for Breast Cancer" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/screening-breast-mri-in-patients-previously-treated-for-breast-cancer/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/screening-breast-mri-in-patients-previously-treated-for-breast-cancer/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2015-10-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Screening Breast MRI in Patients Previously Treated for Breast Cancer" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2015-10-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Screening Breast MRI in Patients Previously Treated for Breast Cancer","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/screening-breast-mri-in-patients-previously-treated-for-breast-cancer/"},"url":"https://clinicaltree.github.io/posts/screening-breast-mri-in-patients-previously-treated-for-breast-cancer/"}</script><title>Screening Breast MRI in Patients Previously Treated for Breast Cancer | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Screening Breast MRI in Patients Previously Treated for Breast Cancer</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Screening Breast MRI in Patients Previously Treated for Breast Cancer</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1446310800" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Oct 31, 2015 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Catherine S. Giess MD</a> </em>, <em> <a href="">Patricia S. Poole MD</a> </em>, <em> <a href="">Sona A. Chikarmane MD</a> </em>, <em> <a href="">Dorothy A. Sippo MD</a> </em>, <em> <a href="">Robyn L. Birdwell MD FACR</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1892 words"> <em>10 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To determine the cancer detection rate and abnormal interpretation rate of screening breast magnetic resonance imaging (MRI) in previously treated breast cancer patients.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Institutional review board–approved retrospective review of the breast MRI database from 2009 to 2011 identified a total of 3297 screening examinations. After excluding genetic mutation carriers, untested first-degree relatives of known mutation carriers, and patients with a history of chest irradiation, there were 1194 (36.2%) examinations in 691 patients previously treated for breast cancer. MRI reports were reviewed to determine MRI findings and breast imaging reporting and data system (BI-RADS) assessments. The longitudinal medical record was reviewed to determine patient demographics and outcomes of imaging surveillance and biopsy.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Mean patient age at initial cancer diagnosis was 46.1 years, and mean patient age during the study interval was 52 years. Cancer detection rate was 10 per 1000 (1%; 95% confidence interval [CI], 0.5%–1.8%]; 12 of 1194 examinations). Overall 10.7% (128 of 1194) of examinations received an abnormal interpretation, including 5.4% (65 of 1194) BI-RADS 4 or 5 and 5.3% (63 of 1194) BI-RADS 3 assessments with a 9.4% positive predictive value (PPV1; 12 of 128 examinations) and a 17.9% PPV3 (12 malignancies per 67 biopsies).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Screening breast MRI in women previously treated for breast cancer detected cancer in 1.0% of examinations, with a 10.7% abnormal interpretation rate, and a PPV for malignancy of 17.9%.</p><p>Breast magnetic resonance imaging (MRI) is recommended as a supplemental screening examination for women at an increased (at least 20%–25%) lifetime risk of developing breast cancer because of its high sensitivity for the detection of invasive malignancies. Groups recommended for supplemental MRI screening include genetic mutation carriers and first-degree untested relatives of genetic mutation carriers; women with Li-Fraumeni, Cowden, Bannayan-Riley-Ruvalcaba syndromes and their untested first-degree relatives; and women with a history of chest irradiation. Evidence supporting supplemental breast MRI screening has been considered to be insufficient to justify routine MRI surveillance for women with a lesser lifetime risk (15%–20%) of developing breast cancer and for women with a previous history of breast cancer .</p><p>Breast cancer survivors remain at risk for recurrent or new breast cancer, and they warrant careful clinical and mammographic follow-up. The 10-year incidence of ipsilateral breast cancer recurrence after lumpectomy and radiation therapy has been reported to be 6.4% in node-negative disease and 8.7% in node-positive disease . In another study reporting 20-year follow-up results in women who had undergone prior breast conservation and radiation therapy, a 14.3% local recurrence rate was reported . Women treated with mastectomy for breast cancer have been reported to develop contralateral breast malignancies ranging from 8.9% to 12% at 20-year follow-up.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="patient-demographics"><span class="mr-2">Patient Demographics</span><a href="#patient-demographics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="screen-detected-malignancies"><span class="mr-2">Screen-Detected Malignancies</span><a href="#screen-detected-malignancies" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Comparison of Women with Cancer-Detected on MRI Compared to Women without Cancer</p><p>Demographic Women with Cancer Women without Cancer_P_ Value Family history of breast cancer in first degree relative .19 Positive 5 167 Negative 7 504 Menopausal status at time of diagnosis .53 Premenopausal 7 451 Postmenopausal 5 204 Perimenopausal 21 Mean age at initial breast cancer diagnosis 48.9 years 46.9 years Mean age at MRI screening 56.7 years 53.0 years</p><p>BIRADS, breast imaging reporting and data system; MRI, magnetic resonance imaging.</p><p>Table 2</p><p>Twelve Malignancies Detected on Screening Breast MRI</p><p>Malignancy Age at Screening MR Diagnosis Age at Initial Cancer Diagnosis Side of Lesion MRI Finding Pathology 1 49 43 Ipsilateral Nonmass enhancement DCIS 2 76 61 Ipsilateral Nonmass enhancement DCIS 3 46 44 Ipsilateral Nonmass enhancement DCIS 4 64 61 Ipsilateral Nonmass enhancement DCIS 5 47 38 Contralateral Mass DCIS 6 48 46 Contralateral Focus IDC, Stage 1A 7 64 59 Ipsilateral Mass IDC 8 26 22 Ipsilateral Mass IDC 9 47 41 Ipsilateral Mass IDC 10 72 41 Ipsilateral Nonmass enhancement IDC 11 59 55 Contralateral Focus IDLC, Stage 1B 12 82 76 Contralateral Mass ILC, Stage 1B</p><p>DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; IDLC, invasive ductal and lobular carcinoma; ILC, invasive lobular carcinoma; MRI, magnetic resonance imaging.</p><p>Ipsilateral lesions were considered breast cancer recurrences, and therefore, no staging is given.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ScreeningBreastMRIinPatientsPreviouslyTreatedforBreastCancer/0_1s20S1076633215002470.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ScreeningBreastMRIinPatientsPreviouslyTreatedforBreastCancer/0_1s20S1076633215002470.jpg" alt="Figure 1, A 59-year-old woman with a history of prior left mastectomy 4 years previously, right-breast subpectoral silicone augmentation, and negative mammography 1 year before screening magnetic resonance imaging (MRI) (a,b) . Postcontrast axial fat-suppressed T1-weighted image (a) ( arrow ) demonstrates a curvilinear focus of enhancement with hyperintensity on fat-suppressed T2-weighted T2 axial imaging (b) ( arrow ), interpreted as possible fat necrosis, with negative ultrasound correlate, assessed as breast imaging reporting and data system (BI-RADS) 3. Six months after MRI, the patient had screening mammography (c) , which showed a one-view asymmetry ( arrows ) with associated calcifications, corresponding to the MRI finding. Stereotactic biopsy showed invasive ductal cancer, stage 1B." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="abnormal-screening-mri-interpretations"><span class="mr-2">Abnormal Screening MRI Interpretations</span><a href="#abnormal-screening-mri-interpretations" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ScreeningBreastMRIinPatientsPreviouslyTreatedforBreastCancer/1_1s20S1076633215002470.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ScreeningBreastMRIinPatientsPreviouslyTreatedforBreastCancer/1_1s20S1076633215002470.jpg" alt="Figure 2, Abnormal magnetic resonance imaging (MRI) interpretation. BIRADS, breast imaging reporting and data system." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Saslow D., Boetes C., Burke W., et. al.: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57: pp. 75-89.</p><li><p>2. Lee C.H., Dershaw D.D., Kopans D., et. al.: Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010; 7: pp. 18-27.</p><li><p>3. Anderson S.J., Wapnir I., Dignam J.J., et. al.: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 2009; 27: pp. 2466-2473.</p><li><p>4. Wapnir I.L., Anderson S.J., Mamounas E.P., et. al.: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials. J Clin Oncol 2006; 24: pp. 2028-2037.</p><li><p>5. Fisher B., Anderson S., Bryant J., et. al.: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: pp. 1233-1241.</p><li><p>6. Gao X., Fisher S.G., Emami B.: Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003; 56: pp. 1038-1045.</p><li><p>7. Houssami N., Abraham L.A., Miglioretti D.L., et. al.: Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA 2011; 305: pp. 790-799.</p><li><p>8. Morris E.A., Comstock C., Lee C., et. al.: ACR BI-RADS magnetic resonance imaging 2013.ACR BI-RADS Atlas: Breast Imaging and Reporting and Data System 2013.2013.American College of RadiologyReston, VA:pp. 1-173.</p><li><p>9. Sickles E.A., D’Orsi C.J.: ACR BI-RADS follow-up and outcome monitoring 2013.ACR BI-RADS Atlas: Breast Imaging and Reporting and Data System 2013.2013.American College of RadiologyReston, VA:pp. 1-73.</p><li><p>10. Viehweg P., Heinig A., Lampe D., et. al.: Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservation therapy. MAGMA 1998; 7: pp. 141-152.</p><li><p>11. Brennan S., Liberman L., Dershaw D.D., et. al.: Breast MRI screening of women with a personal history of breast cancer. AJR 2010; 195: pp. 510-516.</p><li><p>12. Elmore L., Margenthaler J.A.: Breast MRI surveillance in women with prior curative-intent therapy for breast cancer. J Surg Research 2010; 163: pp. 58-62.</p><li><p>13. Schact D.V., Yamaguchi K., Lai J., et. al.: Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. AJR 2014; 202: pp. 289-292.</p><li><p>14. Gweon H.M., Cho N., Han W., et. al.: Breast MR imaging screening in women with a history of breast conservation therapy. Radiology 2014; 272: pp. 366-373.</p><li><p>15. Rosenberg R.D., Yankaskas B.C., Abraham L.A., et. al.: Performance benchmarks for screening mammography. Radiology 2006; 241: pp. 55-66.</p><li><p>16. Breast cancer surveillance consortium, National Cancer Institute. http://breastcancerscreening.cancer.gov/statistics/benchmarks/screening/2009/table6.html . (Accessed on March 3, 2015).</p><li><p>17. Kuhl C.K., Schrading S., Leutner C.C., et. al.: Mammography, ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk of breast cancer. J Clin Oncol 2005; 23: pp. 8469-8476.</p><li><p>18. Warner E., Plewes D.B., Shumak R.S., et. al.: Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high genetic risk for hereditary breast cancer. J Clin Oncol 2001; 19: pp. 3524-3531.</p><li><p>19. Warner E., Plewes D.B., Hill K.A., et. al.: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292: pp. 1317-1325.</p><li><p>20. Kriege M., Brekelmans C.T.M., Boetes C., et. al.: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351: pp. 427-437.</p><li><p>21. Kuhl C.: The current status of breast MR imaging: I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007; 244: pp. 356-378.</p><li><p>22. Lord S.J., Lei W., Craft P., et. al.: A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 2007; 43: pp. 1905-1917.</p><li><p>23. Moore S.G., Shenoy P.J., Fanucchi L., et. al.: Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Services Research 2009; 9: pp. 1-8.</p><li><p>24. Pataky R., Armstrong L., Chia S., et. al.: Cost-effectiveness of MRI for breast cancer screening in BRCA ½ mutation carriers. BMC Cancer 2013; 13: pp. 339. published online July 10, 2013</p><li><p>25. Taneja C., Edelsberg J., Weycker D., et. al.: Cost-effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol 2009; 6: pp. 171-179.</p><li><p>26. Reiner A.S., John E.M., Brooks J.D., et. al.: Risk of asynchronous contralateral breast cancer in noncarriers of BRCA 1 and BRCA 2 mutations with a family history of breast cancer: a report from the women’s environmental cancer and radiation epidemiology study. J Clin Oncol 2012; 31: pp. 433-439.</p><li><p>27. Saltzman B.S., Malone K.E., McDougall J.A., et. al.: Estrogen receptor, progesterone receptor and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer. Breast Cancer Res Treat 2012; 135: pp. 849-855.</p><li><p>28. Kurian A.W., McClure L.A., John E.M., et. al.: Second primary breast cancer occurrence according to hormone receptor status. J Natl Cancer Inst 2009; 101: pp. 1058-1065.</p><li><p>29. Punglia R.S., Hassett M.J.: Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors. J Clin Oncol 2010; 28: pp. 4108-4110.</p><li><p>30. SEER Cancer Statistics Factsheets: Breast Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/breast.html . (Accessed March 5, 2015).</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-22/'>Volume 22</a>, <a href='/categories/issue-11/'>Issue 11</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Screening%20Breast%20MRI%20in%20Patients%20Previously%20Treated%20for%20Breast%20Cancer%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fscreening-breast-mri-in-patients-previously-treated-for-breast-cancer%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Screening%20Breast%20MRI%20in%20Patients%20Previously%20Treated%20for%20Breast%20Cancer%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fscreening-breast-mri-in-patients-previously-treated-for-breast-cancer%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fscreening-breast-mri-in-patients-previously-treated-for-breast-cancer%2F&text=Screening%20Breast%20MRI%20in%20Patients%20Previously%20Treated%20for%20Breast%20Cancer%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/accuracy-of-mri-targeted-in-bore-prostate-biopsy-according-to-the-gleason-score-with-postprostatecto/"><div class="card-body"> <em class="small" data-ts="1446310800" data-df="ll" > Oct 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control—a Targeted Biopsy-Only Strategy with Limited Number of Cores</h3><div class="text-muted small"><p> Rationale and Objectives Accuracy of ultrasound-guided biopsy and Gleason score is limited, and diagnosis of insignificant cancer with Gleason score ≤6 is frequent when extended biopsy schemes are...</p></div></div></a></div><div class="card"> <a href="/posts/balancing-radiation-and-contrast-media-dose-in-single-pass-abdominal-multidetector-ct/"><div class="card-body"> <em class="small" data-ts="1446310800" data-df="ll" > Oct 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Balancing Radiation and Contrast Media Dose in Single-Pass Abdominal Multidetector CT</h3><div class="text-muted small"><p> Rationale and Objectives As both contrast and radiation dose affect the quality of CT images, a constant image quality in abdominal contrast-enhanced multidetector computed tomography (CE-MDCT) co...</p></div></div></a></div><div class="card"> <a href="/posts/breast-cancer-survivors/"><div class="card-body"> <em class="small" data-ts="1446310800" data-df="ll" > Oct 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Breast Cancer Survivors</h3><div class="text-muted small"><p> In this issue of Academic Radiology , authors Giess et al. evaluate screening breast magnetic resonance imaging (MRI) in women previously treated for breast cancer. The authors retrospectively revi...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/satisfaction-of-search-in-chest-radiography-2015/" class="btn btn-outline-primary" prompt="Older"><p>Satisfaction of Search in Chest Radiography 2015</p></a> <a href="/posts/the-diagnostic-value-of-micropure-imaging-in-breast-suspicious-microcalcificaion/" class="btn btn-outline-primary" prompt="Newer"><p>The Diagnostic Value of Micropure Imaging in Breast Suspicious Microcalcificaion</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
